Virucidal and chlamydicidal activities of eye drops with povidone-iodine liposome complex

Area of Science:

• Ophthalmology
• Microbiology
• Drug Delivery Systems

Background:

• Povidone-iodine (PVP-I) is a broad-spectrum microbicide with established efficacy in ophthalmic surgery.
• A novel liposomal complex of PVP-I has been developed for enhanced antiseptic treatment of eye infections.
• Previous studies indicate excellent antimicrobial efficacy of liposomal PVP-I.

Purpose of the Study:

• To evaluate the antimicrobial activity and cytotoxicity of novel liposomal PVP-I formulations.
• To compare the efficacy and tolerability of liposomal PVP-I with aqueous PVP-I solutions.
• To assess the genotoxic potential of liposomal PVP-I formulations.

Main Methods:

• In vitro cell culture studies were conducted to assess antimicrobial activity against specific viruses and bacteria.
• Long-term cytotoxicity experiments were performed on both liposomal and aqueous PVP-I formulations.
• Genotoxicity assays were utilized to evaluate potential DNA damage.

Main Results:

• Liposomal formulations (2.5% and 5% PVP-I) demonstrated antimicrobial activity comparable to aqueous solutions against herpes simplex virus type 1, adenovirus type 8, coxsackievirus A9, and Chlamydia trachomatis.
• Long-term cytotoxicity experiments revealed moderate cytotoxicity for both formulations, with liposomal PVP-I showing better tolerability.
• No evidence of genotoxic activity was found for the tested PVP-I agents.

Conclusions:

• Novel liposomal PVP-I formulations exhibit equivalent antimicrobial efficacy to aqueous solutions at comparable concentrations.
• Liposomal PVP-I offers improved tolerability compared to aqueous solutions, with no observed genotoxicity.
• These findings suggest liposomal PVP-I as a potentially safer and effective option for ophthalmic antiseptic applications.